InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by EPIQ Capital Group, LLC. Officer active across 2 companies, notably Applied Molecular Transport Inc.. Cumulatively, 4 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €200k. Activity tracked since 16 November 2021. The latest transaction was disclosed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to EPIQ Capital Group, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
2,149,292 股Common StockSEC:0001667731-23-000513:0
3,461,764 股Common StockSEC:0001667731-22-000447:0
32,380 股@ US$3.8860.4% 占其流量Common StockSEC:0001667731-22-000196:0
标准退出：2022年8月10日 (T+90)
4,000 股@ US$22.574639.6% 占其流量Common StockSEC:0001667731-21-000314:0
标准退出：2022年2月14日 (T+90)
4 条申报中的 4 条
About EPIQ Capital Group, LLC
EPIQ Capital Group, LLC is a declarant with 5 filings in total. Among the sampled recent filings, the transactions are acquisitions, with EUR 279925 of buys and EUR 0 of sells, over the period from 2021-11-18 to 2023-12-29. The companies mentioned are Applied Molecular Transport Inc. and Lucira Health, Inc.
